Molecular Epidemiology of KPC-Producing Escherichia coli: Occurrence of ST131- fimH30 Subclone Harboring pKpQIL-Like IncFIIk Plasmid
Author(s) -
Jessica A. O’Hara,
Fupin Hu,
Chulsoo Ahn,
Jeremy B. Nelson,
Jesabel I. Rivera,
A. William Pasculle,
Yohei Doi
Publication year - 2014
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02182-13
Subject(s) - plasmid , escherichia coli , replicon , klebsiella pneumoniae , biology , microbiology and biotechnology , cole1 , enterobacteriaceae , trimethoprim , molecular epidemiology , gentamicin , genetics , antibiotics , gene , genotype
Of 20Klebsiella pneumoniae carbapenemase (KPC)-producingEscherichia coli isolates identified at hospitals in western Pennsylvania, 60% belonged to the epidemic ST131-fimH30 subclone. IncFIIk was the most common replicon type for thebla KPC -carrying plasmids (n = 8). All IncFIIk plasmids possessed a scaffold similar to that of pKpQIL, and seven of them were borne by ST131-fimH30 isolates. IncN plasmids conferred resistance to trimethoprim-sulfamethoxazole, and IncA/C plasmids conferred resistance to gentamicin. Threebla KPC -carrying plasmids (IncA/C and IncN) possessedbla SHV-7/12 andqnrA1 orqnrS1 .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom